Authors
Latest:
Navigating the Rapid Growth of Specialty Drugs: Opportunities, Challenges, and the Path AheadHigh-cost novel therapies challenge payers and patients, while biosimilars help balance affordability.
Latest:
The Future of Cancer Drug Development: Advancements, Challenges, and the Transformative Role of AIAI is revolutionizing oncology drug development, enhancing therapeutic identification and reducing approval times, but use of this tool must be carefully implemented to mitigate risks and ensure regulatory compliance.
Latest:
It Is Time to Consider Alternatives to Discipline ProgramsProfessional assistance programs provide pathway for health care professionals to return to practice following treatment for substance use disorder.
Latest:
What Drug Rates Are Reported in Price Transparency Data?It is valuable for pharmacists to understand exactly how price transparency data are sourced, what information can be found, antitrust concerns, and implications for the pharmaceutical industry.
Latest:
Understanding Pharmacogenomics Is Essential for Personalized CarePharmacogenomics can play a role in lowering the cost of health care expenditures, such as shortening hospital stays and reducing emergency department visits.
Latest:
Bacteroidetes: The Jekyll and Hyde of the Human Gut MicrobiomeThe relative abundance of gram-negative Bacteroidetes to other phyla, such as gram-positive Firmicutes, is essential to maintain biodiversity and human gut health.
Latest:
Therapies Under Investigation for Waldenström MacroglobulinemiaThe exciting therapies in the pipeline that are thought to target novel mechanisms in Waldenström macroglobulinemia.
Latest:
Bispecific T-Cell–Engaging Antibodies in B-Cell Lymphoma: Efficacy, Safety, and Practical ConsiderationsThis article reviews the efficacy and safety data for bispecific T-cell engagers and the practical considerations for their implementation across various types of practice sites for the historically difficult-to-treat relapsed/refractory B-cell lymphoma population.
Latest:
Insights on the UK's MHRA International Recognition ProcedureThe UK’s Medicine and Healthcare Products Regulatory Agency (MHRA) introduced changes to streamline its drug approval processes.
Latest:
Expert: Pharmacists Play Critical Role in Vaccination, Public Health Amid Ongoing Viral RisksPharmacists have been central to vaccine distribution since the COVID-19 pandemic, and as viruses spread, they must continue urging patients to stay updated on vaccinations to prevent severe illness and reduce hospitalizations.
Latest:
New Frontiers in Technology: AI Use in Clinical Trial Patient Recruitment in Health SystemsAI is significantly enhancing the efficiency of identifying and enrolling patients.
Latest:
Long Story Short: Cellulitis Can Be Treated in Less Than a WeekDuration of therapy may be just 5 to 6 days for patients without risk factors for complications.
Latest:
One Year Later: Key Issues Impacting Health System Pharmacies During the COVID-19 Vaccine RolloutThis vaccine rollout has become even more crucial for the US health care system, as new mutations of the coronavirus continue to emerge.
Latest:
Updated Clinical Guidelines Outline Optimal Treatment of Helicobacter pylori InfectionFor pharmacists wondering whether bismuth quadruple therapy still reigns as the gold standard, the wait is over—the latest recommendations are here.
Latest:
How Data Can Help Demonstrate the Value of the Health-System Specialty PharmacyInsurers, accountable care organizations, and manufacturers increasingly look for demonstrable clinical outcomes as proof for reimbursement or access to limited distribution networks.
Latest:
As Shortages Continue, Suppliers, Hospitals, and Health Systems Look for New SolutionsHospitals, health systems, and the supply chain are all negatively impacted by drug shortages and are each affected by the decisions of the others.
Latest:
Commonly Overlooked Adverse Effects in the Community, Clinical Pharmacy SettingsAlthough pharmacists possess a wealth of knowledge on AEs, it remains a monumental task to recall the clinical significance of every AE, even with the most commonly used medications.
Latest:
Integration of Palliative Pharmacists to Elevate Oncologic CarePalliative pharmacists are invaluable assets of oncologic care.
Latest:
Managing Sustainable Drug Spend: 5 Trends Reshaping Pharmacy Benefits in 2025The US health care market faces transformative changes in 2025, as biosimilars, GLP-1s, and new pharmacy economics reshape how benefit managers balance innovation with affordability.
Latest:
Educational Resources to Support PatientsPanelists discuss how comprehensive educational resources are essential for empowering patients with TD to better understand their condition, actively participate in their treatment decisions, and achieve optimal outcomes through improved self-management and adherence.
Latest:
Interaction Considerations for Common OTC Drug ClassesAlthough OTC medications are generally considered safe when used as directed, there are some key drug interactions for pharmacists to keep in mind when helping patients choose an OTC product.
Latest:
Pharmacists Have a Significant Role in the Prevention of Travel-Related DiseasesWhen helping individuals prepare for travel, pharmacists must make travel health recommendations and know common travel-related immunizations and additional resources.
Latest:
AHA Statement Reviews Benefits, Risks of Alternative Therapies for Heart FailureThe AHA acknowledged that complementary and alternative medicines are widely used by heart failure patients but warned that there is limited scientific evidence to support their efficacy.
Latest:
Balancing Pharmaceutical Reimbursement and Market Access With the Right PartnerManufacturers must find the right balance in drug pricing, so that medications are appealing to both public and private insurers while still remaining profitable throughout their lifecycle.
Latest:
Case Study: New Treatment Options for Patients With Chronic Lymphocytic LeukemiaWith a better understanding of the underlying pathophysiology of chronic lymphocytic leukemia and the introduction of novel targeted agents, such as Bruton kinase Inhibitors, the prognosis of high-risk patients has changed dramatically.
Latest:
Vax-Innovation: Incorporating the Newly Approved RSV and Pneumococcal Vaccines Into Community Pharmacy WorkflowBest practices to train staff and team members to engage patients and to ease the new vaccine offerings into the workflow are also discussed.
Latest:
St. John’s Wort Could Show Benefit in Major Depressive DisorderPatients with MDD may also seek complementary or alternative therapies in the form of dietary supplements which might be perceived by patients to be natural and safer than medicinal agents.
Latest:
Comparative Oncology: Advances in Cancer Care from Pets to HumansDogs share a number of cancers with humans, including melanoma, non-Hodgkin lymphoma, leukemia, and osteosarcoma.
Latest:
Understand Effective Strategies for Monitoring Topical Dermatological AgentsMatthew Zirwas, MD, highlights the discrepancy between perceived and actual usage, citing studies that reveal patients often overestimate their compliance.
